103 related articles for article (PubMed ID: 10805213)
1. Interleukin 18--interferon gamma inducing factor--a novel player in tumour immunotherapy?
Gołab J
Cytokine; 2000 Apr; 12(4):332-8. PubMed ID: 10805213
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-18.
Dinarello CA
Methods; 1999 Sep; 19(1):121-32. PubMed ID: 10525448
[TBL] [Abstract][Full Text] [Related]
3. [IL-18 and IL-18 receptor].
Kashiwamura S; Okamura H
Nihon Rinsho; 1998 Jul; 56(7):1798-806. PubMed ID: 9702056
[TBL] [Abstract][Full Text] [Related]
4. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
[TBL] [Abstract][Full Text] [Related]
5. Immune enhancement and anti-tumour activity of IL-23.
Hao JS; Shan BE
Cancer Immunol Immunother; 2006 Nov; 55(11):1426-31. PubMed ID: 16676182
[TBL] [Abstract][Full Text] [Related]
6. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens.
Biet F; Locht C; Kremer L
J Mol Med (Berl); 2002 Mar; 80(3):147-62. PubMed ID: 11894141
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of Th1 and Th2 immune responses by IL-18].
Nakanishi K
Kekkaku; 2002 Feb; 77(2):87-93. PubMed ID: 11905033
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of response of rheumatoid synovium cell subsets to interleukin-18 in relation to differential interleukin-18 receptor expression.
Kawashima M; Miossec P
Arthritis Rheum; 2003 Mar; 48(3):631-7. PubMed ID: 12632414
[TBL] [Abstract][Full Text] [Related]
9. Mature form of interleukin 18 is expressed in rheumatoid arthritis synovial tissue and contributes to interferon-gamma production by synovial T cells.
Tanaka M; Harigai M; Kawaguchi Y; Ohta S; Sugiura T; Takagi K; Ohsako-Higami S; Fukasawa C; Hara M; Kamatani N
J Rheumatol; 2001 Aug; 28(8):1779-87. PubMed ID: 11508579
[TBL] [Abstract][Full Text] [Related]
10. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement.
Okazawa A; Kanai T; Watanabe M; Yamazaki M; Inoue N; Ikeda M; Kurimoto M; Ishii H; Hibi T
Am J Gastroenterol; 2002 Dec; 97(12):3108-17. PubMed ID: 12492197
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-18 and host defense against infection.
Dinarello CA; Fantuzzi G
J Infect Dis; 2003 Jun; 187 Suppl 2():S370-84. PubMed ID: 12792854
[TBL] [Abstract][Full Text] [Related]
13. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy by gene transfer with plasmids encoding IL-12/IL-18 is superior to IL-23/IL-18 gene transfer in a rat osteosarcoma model.
Liebau C; Roesel C; Schmidt S; Karreman C; Prisack JB; Bojar H; Merk H; Wolfram N; Baltzer AW
Anticancer Res; 2004; 24(5A):2861-7. PubMed ID: 15517889
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
[TBL] [Abstract][Full Text] [Related]
17. [Interleukin-18].
Fol M; Gościcka T
Postepy Hig Med Dosw; 2003; 57(6):685-99. PubMed ID: 15002164
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
[TBL] [Abstract][Full Text] [Related]
19. IL-18-induced expression of intercellular adhesion molecule-1 in human monocytes: involvement in IL-12 and IFN-gamma production in PBMC.
Yoshida A; Takahashi HK; Nishibori M; Iwagaki H; Yoshino T; Morichika T; Yokoyama M; Kondo E; Akagi T; Tanaka N
Cell Immunol; 2001 Jun; 210(2):106-15. PubMed ID: 11520077
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-18: biological properties and clinical implications.
Lebel-Binay S; Berger A; Zinzindohoué F; Cugnenc P; Thiounn N; Fridman WH; Pagès F
Eur Cytokine Netw; 2000 Mar; 11(1):15-26. PubMed ID: 10705295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
